Chugai Pharmaceutical Co. Ltd. - Ebitda

Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.

The item "Ebitda" stands at 575.67 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.

Chugai Pharmaceutical Co. Ltd.'s third quarter result of 175.93 Billion JPY for the item "Ebitda" represents an increase of 28.98 percent compared to it's second quarter result.

Also, Chugai Pharmaceutical Co. Ltd.'s third quarter result of 175.93 Billion JPY for the item "Ebitda" represents an increase of 10.48 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s third quarter result of 575.67 Billion JPY for the item "Ebitda" represents an increase of 2.99 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.01 percent compared to the value the year prior.
The 1 year change in percent is 6.01.
The 3 year change in percent is 9.93.
The 5 year change in percent is 106.96.
The 10 year change in percent is 583.80.

The Serie's long term average value is 240.76 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 139.11 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2013, to it's latest available value, on 09/30/2025, is +948.27%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is -1.05%.